Atea Pharmaceuticals, Inc. (AVIR)
NASDAQ: AVIR · Real-Time Price · USD
3.770
-0.010 (-0.26%)
Jul 11, 2025, 1:34 PM - Market open
Atea Pharmaceuticals Market Cap
Atea Pharmaceuticals has a market cap or net worth of $322.63 million as of July 11, 2025. Its market cap has increased by 9.76% in one year.
Market Cap
322.63M
Enterprise Value
-100.50M
1-Year Change
9.76%
Ranking
Category
Stock Price
$3.77
Market Cap Chart
Since the IPO on October 30, 2020, Atea Pharmaceuticals's market cap has decreased from $1.94B to $322.63M, a decrease of -83.35%. That is a compound annual growth rate of -31.74%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 10, 2025 | 323.49M | 14.33% |
| Dec 31, 2024 | 282.95M | 11.19% |
| Dec 29, 2023 | 254.48M | -36.48% |
| Dec 30, 2022 | 400.61M | -46.08% |
| Dec 31, 2021 | 742.94M | -78.48% |
| Dec 31, 2020 | 3.45B | 78.13% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 698.13B |
| Johnson & Johnson | 374.84B |
| AbbVie | 335.21B |
| Novo Nordisk | 313.36B |
| UnitedHealth Group | 279.13B |
| Novartis AG | 240.15B |
| Abbott Laboratories | 232.02B |
| AstraZeneca | 217.48B |